ARTICLE | Clinical News
Xiaflex regulatory update
July 27, 2015 7:00 AM UTC
BioSpecifics said Japan approved Xiaflex collagenase clostridium histolyticum to treat Dupuytren’s contracture. BioSpecifics is eligible for a milestone payment upon launch of Xiaflex in Japan, where ...